Anna Vakhrusheva works as a lead bioengineer at Longaevus, where she is able to explore her interests in anti-aging therapies, immunology and drug development. After receiving a PhD in Bioengineering from MSU, Anna started working as CEO of “Betuvax”, a company that works on vaccine development from RnD to clinical trials. Furthermore, Anna has a medical degree, which allows her to bring valuable hands-on experience from both medical and research perspectives to Longaevus.